P01854 (IGHE_HUMAN) Homo sapiens (Human)

Immunoglobulin heavy constant epsilon UniProtKBInterProInteractive Modelling

546 aa; Sequence (Fasta) ; (Isoform 1; Isoform 3)

Available Structures

34 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structure of IgE bound to the ectodomain of FceRIa Heteromer
P01834; P12319;
1-423
NAG;NAG;NAG;NAG;
Assess
The complex of human IgE-Fc with two bound Fab fragments Heteromer
109-425
NAG;
Assess
Structure of a partially disrupted IgE high affinity receptor complex bound to an omalizumab variant Heteromer
P12319;
109-425
NAG;NAG;NAG;NAG;
Assess
THE HIGH-AFFINITY COMPLEX BETWEEN IGE AND ITS RECEPTOR FC EPSILON RI Heteromer
P12319;
108-423
NAG;NAG;
Assess
Focused map for structure of IgE bound to the ectodomain of FceRIa Heteromer
P12319;
108-423
NAG;NAG;NAG;
Assess
Structure of extended IgE-Fc in complex with two anti-IgE Fabs Heteromer
111-425
NAG;NAG;
Assess
Crystal structure of the human IgE-Fc bound to its B cell receptor derCD23 Heteromer
P06734;
114-421
NAG;NAG;
Assess
Structure of the human ige-fc bound to its high affinity receptor fc(epsilon)ri(alpha) Heteromer
P12319;
211-425
NAG;NAG;NAG;NAG;NAG;SO4;CPS;
Assess
Structure of IgE complexed with omalizumab Heteromer
213-426
NAG; 22×SO4;
Assess
Crystal structure of IgE complexed with E2_79, an anti-IgE inhibitor Heteromer
213-426
Assess
IgE-Fc in complex with single domain antibody 026 Heteromer
215-426
NAG;GOL;
Assess
Complex of IgE and Ligelizumab Heteromer
215-426
NAG;NAG;
Assess
IgE-Fc in complex with DARPins E2_79 and E3_53 Heteromer
216-426
NAG;NAG;
Assess
Crystal structure of IgE Fc in complex with a neutralizing antibody Heteromer
216-426
NAG;
Assess
IgE-Fc in complex with HAE Heteromer
215-425
NAG;NAG;NAG;PO4;ACT;EDO;MAN;GOL;
Assess
Crystal structure of the human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23 Heteromer
P06734;
216-426
NAG;
Assess
Primitive triclinic crystal form of the human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD… Heteromer
P06734;
216-426
NAG;
Assess
Crystal structure of the calcium2+-bound human IgE-Fc(epsilon)3-4 bound to its B cell receptor derC… Heteromer
P06734;
216-426
NAG;CA;
Assess
IgE-Fc in complex with omalizumab variant C02 Heteromer
217-425
NAG;NAG;EDO;PO4;
Assess
IgE-Fc in complex with 813 Heteromer
217-425
NAG;MAN;NAG;NA;
Assess
IgE-Fc in complex with omalizumab scFv Heteromer
217-425
NAG;NAG;MAN;NAG;
Assess
Crystal structure of human IgE-Fc epsilon 3-4homo-6-mer216-425
NAG;NAG;NAG;BMA;PEG;PO4;EDO;
Assess
Crystal structure of human IgE-Fc epsilon 3-4homo-4-mer216-427
NAG;NAG;NAG;PEG;EDO;
Assess
The high resolution crystal structure of IgE Fchomo-2-mer105-427
NAG;SO4;GOL;TRS;PG4;
Assess
Human IgE-Fc crystal structurehomo-2-mer105-426
NAG;NAG;PG0;EDO;PEG;AE3;
Assess
The crystal structure of IgE Fc reveals an asymmetrically bent conformationhomo-2-mer108-427
NAG;NAG;SO4;GOL;
Assess
An engineered disulfide bond reversibly traps the IgE-Fc3-4 in a closed, non-receptor binding confo…homo-2-mer214-426
NAG;
Assess
Crystal structure of the IgE-Fc3-4 domainshomo-2-mer216-425
NAG;NAG;
Assess
Crystal structure of IgE-Fc epsilon 3-4homo-2-mer217-425
NAG;SO4;EDO;PEG;
Assess
Crystal structure of the IgE-Fc3-4 domainshomo-2-mer217-425
NAG;
Assess
Crystal structure of the IgE-Fc3-4 domainshomo-2-mer217-425
NAG;
Assess
CRYSTAL STRUCTURE ANALYSIS OF THE HUMAN IGE-FC CEPSILON3-CEPSILON4 FRAGMENT.homo-2-mer217-424
Assess
THE CRYSTAL STRUCTURE OF IGE FC MUTANT - P333Cmonomer108-426
NAG;SO4;PG4;
Assess
THE SOLUTION STRUCTURE OF THE C EPSILON2 DOMAIN FROM IGEmonomer106-210
Assess

9 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
9eq4.1.Dmonomer0.844-428
98.82
Assess
9eq4.1.Amonomer0.834-428
98.82
Assess
1o0v.1.Ahomo-2-mer0.82108-427
NAG;NAG;99.08
Assess
7wso.1.Cmonomer0.59217-518
34.14
Assess
7wso.1.Amonomer0.57217-518
34.14
Assess
7xq8.1.Amonomer0.553-521
27.85
Assess
7xq8.1.Cmonomer0.553-521
27.85
Assess
8ema.1.Amonomer0.535-521
29.07
Assess
8ema.1.Bmonomer0.525-521
29.07
Assess

12 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 19eq4.1.Dmonomer0.821-427
100.00
Assess
Isoform 19eq3.1.Amonomer0.821-428
NAG;100.00
Assess
Isoform 17lf9.1.Ahomo-2-mer0.585-200
20.92
Assess
Isoform 13liz.1.Cmonomer0.5321-207
22.55
Assess
Isoform 15b4m.1.Bmonomer0.53229-425
19.59
Assess
Isoform 38c1c.1.Dmonomer0.841-423
100.00
Assess
Isoform 38c1c.1.Amonomer0.841-423
100.00
Assess
Isoform 31o0v.1.Ahomo-2-mer0.82108-427
NAG;98.77
Assess
Isoform 37xq8.1.Amonomer0.593-469
27.85
Assess
Isoform 37xq8.1.Cmonomer0.593-469
27.85
Assess
Isoform 38ema.1.Amonomer0.575-469
29.30
Assess
Isoform 38ema.1.Bmonomer0.555-469
29.30
Assess